Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 16, 2016
A modified treat-and-extend regimen of aflibercept for treatment-naïve patients with neovascular age-related macular degenerationMasayuki Ohnaka, Yoshimi Nagai, Kenichiro Sho, et al.Clinical Ophthalmology (Auckland, N.Z.)|August 1, 2013
Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)Tsuyoshi Otsuji, Yoshimi Nagai, Kenichiro Sho, et al.Nippon Ganka Gakkai Zasshi|July 1, 2006
[Evaluation of cases of polypoidal choroidal vasculopathy showing classic choroidal neovascularization in their natural course]Tsuyoshi Otsuji, Akiko Tsumura, Kanji Takahashi, et al.American Journal of Ophthalmology|May 7, 2002
Polypoidal choroidal vasculopathy: natural historyMasanobu Uyama, Mitsumasa Wada, Yoshimi Nagai, et al.American Journal of Ophthalmology|October 23, 2009
Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularizationYasushi Ikuno, Yoshimi Nagai, Satoshi Matsuda, et al.Retina (Philadelphia, Pa.)|September 30, 2017
LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDYNikolle W Tan, Kyoko Ohno-Matsui, Hyoung J Koh, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|October 15, 2003
Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristicsKenichiro Sho, Kanji Takahashi, Haruhiko Yamada, et al.Patient Preference and Adherence|March 28, 2020
Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice ExperimentTakeshi Joko, Yoshimi Nagai, Ryusaburo Mori, et al.Lancet (London, England)|June 5, 2002
Genome and virulence determinants of high virulence community-acquired MRSATadashi Baba, Fumihiko Takeuchi, Makoto Kuroda, et al.Journal of Human Genetics|July 29, 2018
Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degenerationMasato Akiyama, Atsushi Takahashi, Yukihide Momozawa, et al.Pageof 2